Stem Cell Mobilization with G-CSF versus Cyclophosphamide plus G-CSF in Mexican Children

Author:

Meraz José Eugenio Vázquez1,Arellano-Galindo José2,Avalos Armando Martínez3,Mendoza-García Emma4,Jiménez-Hernández Elva5

Affiliation:

1. Banco de Sangre, Hospital General de Ecatepec las Américas, Simón Bolivar esq. Libertadores de América Fracc. las Américas, 55076 Ecatepec de Morelos, MEX, Mexico

2. Area de Virología, Laboratorio de Microbiología y Enfermedades Infecciosas, Hospital Infantil de México Federico Gómez, Mexico

3. Departamento de Oncología, Instituto Nacional de Pediatría, Mexico

4. Laboratorio de Hematología e Investigación, Hospital General de México, OD and Laboratorio Clínico, Central Hospital Infantil de México Federico Gómez, Ciudad de México, DF, Mexico

5. Departamento de Hematología Pediátrica, UMAE CMN la Raza IMSS, Mexico

Abstract

Fifty-six aphaereses were performed in 23 pediatric patients with malignant hematological and solid tumors, following three different protocols for PBPC mobilization and distributed as follows: A: seventeen mobilized with 4 g/m2of cyclophosphamide (CFA) and 10 μg/kg/day of granulocyte colony stimulating factor (G-CSF), B: nineteen with CFA + G-CSF, and C: twenty only with G-CSF when the WBC count exceeded 10 × 109/L. The average number of MNC/kg body weight (BW)/aphaeresis was 0.4 × 108(0.1–1.4), 2.25 × 108(0.56–6.28), and 1.02 × 108(0.34–2.5) whereas the average number of CD34+ cells/kg BW/aphaeresis was 0.18 × 106/kg (0.09–0.34), 1.04 × 106(0.19–9.3), and 0.59 × 106(0.17–0.87) and the count of CFU/kg BW/aphaeresis was 1.11 × 105(0.31–2.12), 1.16 × 105(0.64–2.97), and 1.12 × 105(0.3–6.63) in groups A, B, and C, respectively. The collection was better in group B versus group A (p=0.007andp=0.05, resp.) and in group C versus group A (p=0.08andp=0.05, resp.). The collection of PBPCs was more effective in the group mobilized with CFM + G-CSF when the WBC exceeded 10 × 103/μL in terms of MNC and CD34+ cells and there was no toxicity of the chemotherapy.

Publisher

Hindawi Limited

Subject

Cell Biology,Molecular Biology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3